Dendritic cells and the maintenance of self-tolerance

Immunologic Research

Volumn 50, Issue 2-3, 2011, Pages 124-129

  Morel, Penelope A ^a   Turner, Michael S ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Dendritic cells; Regulatory T cells; Type 1 diabetes

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CD8ALPHA ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MONOCLONAL ANTIBODY CD3; OX40 LIGAND; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; FETAL CALF SERUM; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 79961165724     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8217-y     Document Type: Review

References (46)

1. AI Proietto S van Dommelen P Zhou A Rizzitelli A D'Amico RJ Steptoe SH Naik MH Lahoud Y Liu P Zheng K Shortman L Wu 2008 Dendritic cells in the thymus contribute to T-regulatory cell induction Proc Natl Acad Sci USA 105 19869 19874 19073916 10.1073/pnas.0810268105 1:CAS:528:DC%2BD1cXhsFCltrjI
2. + T regulatory cells The Journal of Immunology 184 3433 3441 20181882 10.4049/jimmunol.0904028 1:CAS:528:DC%2BC3cXjs1Wrt78%3D
3. SF Ziegler 2006 FOXP3: of mice and men Annu Rev Immunol 24 209 226 16551248 10.1146/annurev.immunol.24.021605.090547 1:CAS:528:DC%2BD28XkvFSqt7s%3D
4. + T cells J Immunol 154 5071 5079 7730613 1:CAS:528:DyaK2MXlsVyksbk%3D
5. T Korn E Bettelli M Oukka VK Kuchroo 2009 IL-17 and Th17 cells Annu Rev Immunol 27 485 517 19132915 10.1146/annurev.immunol.021908.132710 1:CAS:528:DC%2BD1MXlsFSltrY%3D
6. MC Fantini C Becker G Monteleone F Pallone PR Galle MF Neurath 2004 Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 J Immunol 172 5149 5153 15100250 1:CAS:528:DC%2BD2cXjt1Cks7s%3D (Pubitemid 38542009)
7. + regulatory T cells from peripheral Foxp3 precursors Blood 110 4293 4302 17699744 10.1182/blood-2007-05- 088831 1:CAS:528:DC%2BD1cXotF2r (Pubitemid 351377794)
8. ES Chambers CM Hawrylowicz 2011 The impact of vitamin D on regulatory T cells Curr Allergy Asthma Rep 11 29 36 21104171 10.1007/s11882-010-0161-8 1:CAS:528:DC%2BC3MXlsFOhsg%3D%3D
9. D Mucida Y Park G Kim O Turovskaya I Scott M Kronenberg H Cheroutre 2007 Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid Science 317 256 260 17569825 10.1126/science.1145697 1:CAS:528: DC%2BD2sXnsFaqt78%3D (Pubitemid 47076203)
10. F Baeke T Takiishi H Korf C Gysemans C Mathieu 2010 Vitamin D: modulator of the immune system Curr Opin Pharmacol 10 482 496 20427238 10.1016/j.coph.2010.04.001 1:CAS:528:DC%2BC3cXpsFKhtr0%3D
11. PA Morel MS Turner 2010 Designing the optimal vaccine: the importance of cytokines and dendritic cells The Open Vaccine Journal 3 7 17 10.2174/1875035401003010007 1:CAS:528:DC%2BC3cXis1GgsL4%3D
12. LS Wicker J Clark HI Fraser VES Garner A Gonzalez-Munoz B Healy S Howlett K Hunter D Rainbow RL Rosa LJ Smink JA Todd LB Peterson 2005 Type 1 diabetes genes and pathways shared by humans and NOD mice J Autoimmun 25 29 33 16257508 10.1016/j.jaut.2005.09.009 1:CAS:528:DC%2BD2MXht1Ghs73O (Pubitemid 41728041)
13. MS Anderson JA Bluestone 2005 The NOD mouse: a model of immune dysregulation Annu Rev Immunol 23 447 485 15771578 10.1146/annurev.immunol.23. 021704.115643 1:CAS:528:DC%2BD2MXktFOjurg%3D (Pubitemid 40563177)
14. M Feili-Hariri X Dong SM Alber SC Watkins RD Salter PA Morel 1999 Immunotherapy of NOD mice with bone marrow-derived dendritic cells Diabetes 48 2300 2308 10580417 10.2337/diabetes.48.12.2300 1:CAS:528:DyaK1MXnslOqt70%3D (Pubitemid 30395420)
15. M Feili-Hariri DH Falkner PA Morel 2002 Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice Eur J Immunol 32 2021 2030 12115623 10.1002/1521-4141(200207)32:7<2021::AID- IMMU2021>3.0.CO;2-J 1:CAS:528:DC%2BD38XlsFaju70%3D (Pubitemid 34814559)
16. M Feili-Hariri DH Falkner A Gambotto GD Papworth SC Watkins PD Robbins PA Morel 2003 Dendritic cells transduced to express IL-4 prevent diabetes in nonobese diabetic mice with established insulitis Human Gene Ther 14 13 23 10.1089/10430340360464679 1:CAS:528:DC%2BD3sXhtlCiurc%3D (Pubitemid 36126684)
17. M Feili-Hariri DH Falkner PA Morel 2005 Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy J Leukoc Biol 78 656 664 15961574 10.1189/jlb.1104631 1:CAS:528:DC%2BD2MXhtVSksb3O (Pubitemid 41292088)
18. I Zanoni F Granucci 2011 The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance Autoimmunity 44 23 32 20670116 10.3109/08916931003782148 1:CAS:528:DC%2BC3MXlt1ylsw%3D%3D
19. G Darrasse-Jeze S Deroubaix H Mouquet GD Victora T Eisenreich KH Yao RF Masilamani ML Dustin A Rudensky K Liu MC Nussenzweig 2009 Feedback control of regulatory T cell homeostasis by dendritic cells in vivo J Exp Med 206 1853 1862 19667061 10.1084/jem.20090746 1:CAS:528:DC%2BD1MXhtVyitLnM
20. + T cell tolerance J Exp Med 196 1627 1638 12486105 10.1084/jem.20021598 1:CAS:528:DC%2BD38XpslWlu7o%3D (Pubitemid 36026474)
21. D Hawiger K Inaba Y Dorsett M Guo K Mahnke M Rivera JV Ravetch RM Steinman MC Nussenzweig 2001 Dendritic cells induce peripheral T Cell unresponsiveness under steady state conditions in vivo J Exp Med 194 769 780 11560993 10.1084/jem.194.6.769 1:CAS:528:DC%2BD3MXmvFGgsrY%3D (Pubitemid 32983013)
22. H von Boehmer 2005 Peptide-based instruction of suppressor commitment in naive T cells and dynamics of immunosuppression in vivo Scand J Immunol 62 Suppl 1 49 54 10.1111/j.1365-3083.2005.01609.x (Pubitemid 41137561)
23. + regulatory T cell induction and expansion J Immunol 183 4895 4903 19801514 10.4049/jimmunol.0901459 1:CAS:528: DC%2BD1MXht1WhsLnO
24. JD Katz B Wang K Haskins C Benoist D Mathis 1993 Following a diabetogenic T cell from genesis through pathogenesis Cell 74 1089 1100 8402882 10.1016/0092-8674(93)90730-E 1:CAS:528:DyaK3sXmt1ehtbo%3D (Pubitemid 23289465)
25. V Judkowski C Pinilla K Schroder L Tucker N Sarvetnick DB Wilson 2001 Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice J Immunol 166 908 917 11145667 1:CAS:528:DC%2BD3MXlvVWisA%3D%3D (Pubitemid 32060245)
26. K Kretschmer I Apostolou D Hawiger K Khazaie MC Nussenzweig H von Boehmer 2005 Inducing and expanding regulatory T cell populations by foreign antigen Nat Immunol 6 1219 1227 16244650 10.1038/ni1265 1:CAS:528:DC%2BD2MXhtlShur3J (Pubitemid 43045633)
27. + cells J Exp Med 205 565 574 18283119 10.1084/jem.20071477 1:CAS:528:DC%2BD1cXjs1ahtbs%3D (Pubitemid 351439304)
28. S Sauer L Bruno A Hertweck D Finlay M Leleu M Spivakov ZA Knight BS Cobb D Cantrell E O'Connor KM Shokat AG Fisher M Merkenschlager 2008 T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR Proc Natl Acad Sci USA 105 7797 7802 18509048 10.1073/pnas.0800928105 1:CAS:528: DC%2BD1cXntF2rtbY%3D (Pubitemid 351872718)
29. GM Delgoffe TP Kole Y Zheng PE Zarek KL Matthews B Xiao PF Worley SC Kozma JD Powell 2009 The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 832 844 19538929 10.1016/j.immuni.2009.04.014 1:CAS:528:DC%2BD1MXpsFCnurw%3D
30. K Lee P Gudapati S Dragovic C Spencer S Joyce N Killeen MA Magnuson M Boothby 2010 Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways Immunity 32 743 753 20620941 10.1016/j.immuni.2010.06.002 1:CAS:528: DC%2BC3cXovVahtbs%3D
31. M Battaglia A Stabilini M-G Roncarolo 2005 Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells Blood 105 4743 4748 15746082 10.1182/blood-2004-10-3932 1:CAS:528:DC%2BD2MXlsVWju7s%3D (Pubitemid 40807298)
32. S Basu T Golovina T Mikheeva CH June JL Riley 2008 Cutting edge: Foxp3-mediated induction of Pim 2 allows human T regulatory cells to preferentially expand in rapamycin J Immunol 180 5794 5798 18424697 1:CAS:528:DC%2BD1cXkvVequ7Y%3D
33. L Strauss TL Whiteside A Knights C Bergmann A Knuth A Zippelius 2007 Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin J Immunol 178 320 329 17182569 1:CAS:528:DC%2BD2sXnvVWn (Pubitemid 46033615)
34. Morel PA, Srinivas M, Turner MS, Fuschiotti P, Munshi R, Bahar I, Feili-Hariri M, Ahrens ET. Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules. J Leuk Biol 2011;Under Revsion.
35. A Hoshino Y Tanaka H Akiba Y Asakura Y Mita T Sakurai A Takaoka S Nakaike N Ishii K Sugamura H Yagita K Okumura 2003 Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma Eur J Immunol 33 861 869 12672051 10.1002/eji.200323455 1:CAS:528:DC%2BD3sXjtValtbk%3D (Pubitemid 36546673)
36. T So M Croft 2007 Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells J Immunol 179 1427 1430 17641007 1:CAS:528:DC%2BD2sXnvVyntro%3D
37. ET Ahrens R Flores H Xu PA Morel 2005 In vivo imaging platform for tracking immunotherapeutic cells Nat Biotechnol 23 983 987 16041364 10.1038/nbt1121 1:CAS:528:DC%2BD2MXntVSrtrY%3D (Pubitemid 41114032)
38. M Srinivas PA Morel LA Ernst DH Laidlaw ET Ahrens 2007 Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model Magn Reson Med 58 725 734 17899609 10.1002/mrm.21352 1:CAS:528:DC%2BD2sXht1SrtrzF (Pubitemid 47556877)
39. C Haase M Ejrnaes AE Juedes T Wolfe H Markholst MG von Herrath 2005 Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo Blood 106 4225 4233 16118326 10.1182/blood-2005-03-0975 1:CAS:528:DC%2BD2MXhtlaltrrI (Pubitemid 41775930)
40. E Carrasco-Marin J Shimizu O Kanagawa E Unanue 1996 The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders J Immunol 156 450 458 8543793 1:CAS:528:DyaK28XksV2lsQ%3D%3D
41. H Kishimoto J Sprent 2001 A defect in central tolerance in NOD mice Nat Immunol 2 1025 1031 11668341 10.1038/ni726 1:CAS:528:DC%2BD3MXotF2gtrk%3D (Pubitemid 33069497)
42. SO Ryan MS Turner J Gariépy OJ Finn 2010 Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses Cancer Res 70 5788 5796 20587526 10.1158/0008-5472.CAN- 09-4519 1:CAS:528:DC%2BC3cXovVanurw%3D
43. D Schmid M Pypaert C Munz 2007 Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes Immunity 26 79 92 17182262 10.1016/j.immuni.2006.10.018 1:CAS:528:DC%2BD2sXhsFKitL0%3D (Pubitemid 46109341)
44. J Nedjic M Aichinger J Emmerich N Mizushima L Klein 2008 Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance Nature 455 396 400 18701890 10.1038/nature07208 1:CAS:528:DC%2BD1cXhtFams7nO
45. HW Virgin B Levine 2009 Autophagy genes in immunity Nat Immunol 10 461 470 19381141 10.1038/ni.1726 1:CAS:528:DC%2BD1MXkslOgsro%3D
46. C Jagannath DR Lindsey S Dhandayuthapani Y Xu RL Hunter Jr NT Eissa 2009 Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells Nat Med 15 267 276 19252503 10.1038/nm.1928 1:CAS:528:DC%2BD1MXisVOrt7w%3D